GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Video_Solomon_Camidge_ALK_QnA.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-086_Lung-Audio_Solomon_Camidge_ALK_QnA.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Audio_Camidge_on_ALK-Positive.mp3
Category:Lung-Cancer-Audio -- posted at: 5:30pm PDT

Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.

Direct download: GRACEcast-085_Lung-Video_Camidge_on_ALK-Positive.m4v
Category:Lung-Cancer-Video -- posted at: 5:29pm PDT